AERI

Aerie Pharmaceuticals, Inc.

Delisted

AERI was delisted on the 18th of November, 2022.

53 hedge funds and large institutions have $298M invested in Aerie Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
1.53%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
13
Increased
23
Reduced
12
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Bank of America
51
Bank of America
North Carolina
$1K -$1.7K -63 -63%
BNP Paribas Financial Markets
52
BNP Paribas Financial Markets
France
$204 -$1.29K -82 -86%
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$139 +$139 +6,539 New
BC
54
Broadfin Capital
New York
-$7.03M -391,232 Closed
GPP
55
Great Point Partners
Connecticut
-$5.54M -308,429 Closed
Millennium Management
56
Millennium Management
New York
-$1.92M -106,940 Closed
Fidelity Investments
57
Fidelity Investments
Massachusetts
-$1.8M -100,000 Closed
Alyeska Investment Group
58
Alyeska Investment Group
Illinois
-$925K -51,508 Closed
SCA
59
SAC Capital Advisors
Connecticut
-$223K -12,418 Closed
KeyBank National Association
60
KeyBank National Association
Ohio
-$203K -11,308 Closed
RCP
61
Rothschild Capital Partners
New York
-$180K -10,000 Closed
TRCT
62
Tower Research Capital (TRC)
New York
-$25K -1,409 Closed